+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSII and ICT in treating Type I diabetic individuals

CSII and ICT in treating Type I diabetic individuals

Diabetes Care 6(2): 201

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 042429394

Download citation: RISBibTeXText

PMID: 6343026

DOI: 10.2337/diacare.6.2.210b

Related references

Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients. Przeglad Lekarski 62(1): 49-53, 2005

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 28(3): 533-538, 2005

CSII in type 2 diabetic patients. Diabetes Research and Clinical Practice 74(Suppl. 2): S116-S118, 2006

Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis. Ontario Health Technology Assessment Series 9(20): 1-58, 2009

Macrosomia in well controlled CSII treated Type I diabetic pregnancy. Gynecological Endocrinology 24(11): 611-613, 2008

Short acting insulin analogues for treating diabetic patients with CSII (continuous subcutaneous insulin infusion). Orvosi Hetilap 147(46): 2223-2226, 2007

A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. International Journal of Clinical Practice 62(12): 1858-1863, 2009

Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII. Hormone and Metabolic Research. Supplement Series 18: 74-77, 1988

A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSII. Diabetes Care 5(5): 466-471, 1982

Effect of acarbose on sucrose utilization during prolonged muscular exercise in csii treated type 1 diabetic patients. Diabetes Research & Clinical Practice 5(SUPPL 1): S535, 1988

What are capillary blood ketone levels in type 1 diabetic patients using CSII in normal conditions of insulin delivery?. Diabetes and Metabolism 30(6): 543-547, 2005

Host-Parasite Interactions in Individuals with Type 1 and 2 Diabetes Result in Higher Frequency of Ascaris lumbricoides and Giardia lamblia in Type 2 Diabetic Individuals. Journal of Diabetes Research 2018: 4238435, 2018

Effect of moderate ethanol ingestion on overnight diabetes control and hormone secretion in type 1 diabetic patients csii. Diabetologia 34(SUPPL 2): A188, 1991

Retrospective analysis of daily glucose profile in type 1 diabetic patients with continuous subcutaneous insulin infusion (CSII). Diabetes Research and Clinical Practice 16(3): 197-202, 1992

Induction of long-term glycaemic control in diet-resistant type 2 diabetic patients by two-week CSII treatment. Diabetologia 36(SUPPL 1): A76, 1993